Toggle sidebar
定价
登录
ex vivo hypoimmune therapy
搜索文档
Sana Biotechnology Stock: Promising T1D Science, But Wait For Dips
Seeking Alpha
·
2026-01-19 20:40
公司概况 - Sana Biotechnology Inc (SANA) 是一家生物技术公司 开发体外低免疫疗法和体内基于融合素的递送系统 用于治疗癌症和自身免疫性疾病 [1] 技术平台 - 公司拥有一个体外平台 [1]
Sana Biotechnology(US:SANA)
Cancer treatment
Autoimmune diseases treatment
Biotech
ex vivo hypoimmune therapy
in vivo fusogen-based delivery system
Cancer treatment
Autoimmune diseases treatment
Biotech
ex vivo hypoimmune therapy
in vivo fusogen-based delivery system
